The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoi… (NCT06981026) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy
Czechia200 participantsStarted 2026-01-01
Plain-language summary
The study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.
Who can participate
Age range
40 Years – 80 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* Biopsy-confirmed localized prostate cancer (ICD code C.61).
* Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).
* Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.
* No known urethral stricture or colostomy or chronic urinary catheterization.
* No medical or current psychiatric disorders that precludes their participation in the study.
* Status of the musculoskeletal system allowing physical exercise.
* Urinary continent at baseline.
* Has reliable internet and the skills/knowledge to use technologies use for the study.
Exclusion criteria:
* Other malignant tumors, except for benign skin carcinoma.
* Active treatment for other oncological diagnoses.
* Presence of preoperative urinary incontinence.
* Diagnosed mental or cognitive disorders.
* Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence.
* Severe musculoskeletal disorders preventing active exercise
* Inability to use required technologies
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Reduction in Early Postoperative Incontinence
Timeframe: Baseline evaluated at 30 days before surgery. Evaluated at 6 weeks, 3 months, and 6 months post-surgery.
2
Time to full Continence Recovery
Timeframe: 3 - 6 months post-surgery
3
Six-Minute Walk Test Distance
Timeframe: 2 weeks pre-surgery, 3 months and 6 months post-surgery
4
Balance Test Composite Score
Timeframe: 2 weeks pre-surgery, 3 months and 6 months post-surgery
5
Lower Limb and abdominal Muscle Strength (Isometric)
Timeframe: 2 weeks pre-surgery, 3 months and 6 months post-surgery